ArticleTrials2023

Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.

Chris A Rees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.